Advertisement
Loading...

Aytu BioPharma, Inc.

AYTU•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$2.19
$-0.08(-3.52%)
U.S. Market opens in 28h 24m

Aytu BioPharma, Inc. (AYTU) Stock Overview

Explore Aytu BioPharma, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap17.7M
P/E Ratio-0.68
EPS (TTM)$-4.61
ROE-1.49%
Fundamental Analysis

AI Price Forecasts

1 Month$2.39
3 Months$3.20
1 Year Target$2.67

AYTU Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Aytu BioPharma, Inc. (AYTU) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 28.07, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $2.67.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.68 and a market capitalization of 17.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-3.52%
5-Day Change
-12.05%
1-Month Change
-15.44%
3-Month Change
2.82%
6-Month Change
4.78%
Year-to-Date (YTD) Change
-15.77%
1-Year Change
-15.44%
3-Year Change
22.35%
5-Year Change
-98.05%
All-Time (Max) Change
-100.00%

Contact Information

https://aytubio.com
720 437 6580
373 Inverness Parkway, Englewood, CO, 80112

Company Facts

102 Employees
IPO DateSep 25, 2008
CountryUS
Actively Trading

Frequently Asked Questions